SC
PTCT icon

Syon Capital’s PTC Therapeutics PTCT Stock Holding History

Syon Capital’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
3,735
+59
+2% +$4.26K 0.01% 790
2026
Q1 		$250K Buy
3,676
+21
+0.6% +$1.49K 0.01% 799
2025
Q4 		$278K Sell
3,655
-39
-1% -$2.83K 0.01% 770
2025
Q3 		$227K Buy
+3,694
New +$192K 0.01% 751
2025
Q2 		– Sell
-4,020
Closed -$205K – 772
2025
Q1 		$205K Buy
+4,020
New +$201K 0.02% 536

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Syon Capital's PTCT Position: Q2 2026 in Review

Syon Capital increased its PTC Therapeutics (PTCT) stake by 1.6% in Q2 2026, buying an estimated $4.26K and bringing the position to 3,735 shares worth $305K. The position accounts for 0.01% of the portfolio, ranked #790.

Syon Capital first reported a position in PTCT in Q1 2025 and has held it in 5 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Syon Capital held 3,735 shares of PTC Therapeutics worth $305K as of Q2 2026.
  • Syon Capital bought 59 PTC Therapeutics shares in Q2 2026, an estimated $4.26K.
  • PTC Therapeutics made up 0.01% of Syon Capital's portfolio in Q2 2026, its #790 holding.
  • Syon Capital first reported a position in PTC Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.